← Eichor
Condition: Axillary Lymph Nodes Dissection Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Axillary Lymph Nodes Dissection

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

TAD After Chemotherapy in Locally Advanced Breast Cancer
Phase N/A · 2 location(s) · Hospital Universitari de Bellvitge · NCT05763641Axillary Radiotherapy or Axillary Lymph Node Dissection in Patients With Clinically Node- Positive Breast Cancer Undergo
NA · 54 location(s) · University Hospital, Basel, Switzerland · NCT07140172Role of Axillary Lymph Node Dissection for Residual MACROMETASTASES After NEOADJUVANT Chemotherapy in Patients With HER2
Phase N/A · 1 location(s) · University Hospital, Basel, Switzerland · NCT07546695A Study Evaluating the Feasibility and Compliance of Manual Lymphatic Drainage Comparing Indocyanine-Green (ICG) Guided
Phase 2 · 1 location(s) · University of Florida · NCT06327490Lymphedema Evaluation After Adjuvant Hypofractionated Radiotherapy for 1-2 Macrometastatic Sentinel Lymph Nodes
Phase N/A · 1 location(s) · European Institute of Oncology · NCT06321653Nomogram to Predict Breast Cancer Related Lymphedema
NA · 1 location(s) · Wuhan University · NCT04665882Targeted Axillary Dissection (TAD) in Early-stage Node Positive Breast Cancer
NA · 3 location(s) · Jewish General Hospital · NCT04671511The LYMPH Trial - Microsurgical Versus Conservative Treatment of Chronic Breast Cancer Associated Lymphedema
NA · 36 location(s) · University Hospital, Basel, Switzerland · NCT05890677Carbon Suspension vs. Metallic Marker for Axillary Lymph Node Marking in Breast Cancer After Neoadjuvant Therapy
NA · 1 location(s) · Saint Petersburg State University, Russia · NCT07106112TAD in Primary Breast Cancer With Initially ≥ 3 Suspicious Lymph Nodes
Phase N/A · 1 location(s) · Kliniken Essen-Mitte · NCT05462457Upfront Targeted Axillary Dissection for Luminal Breast Cancer With Limited Axillary Involvement
Phase N/A · 14 location(s) · European Institute of Oncology · NCT07278726Audit of Targeted Sentinel Node Biopsy (TSNB) in Patients With Limited Nodal Disease Undergoing Primary Surgery
Phase N/A · 12 location(s) · University Hospitals of Derby and Burton NHS Foundation Trus · NCT07085442Omission of ALND in Breast Cancer Patients With Axillary pCR
NA · 1 location(s) · The First Affiliated Hospital with Nanjing Medical Universit · NCT05939830AXillary Surgery After NeoAdjuvant Treatment
Phase N/A · 1 location(s) · European Breast Cancer Research Association of Surgical Tria · NCT04373655Axillary Management in Breast Cancer Patients With Needle Biopsy Proven Nodal Metastases After Neoadjuvant Chemotherapy
NA · 98 location(s) · University Hospitals of Derby and Burton NHS Foundation Trus · NCT04109079ILR to Prevent BRCL_MCC 23608
NA · 3 location(s) · University of South Florida · NCT07127003Intraoperative Neuromonitoring (IONM) and Bipolar Electrocautery (BE) During Axillary Lymph Node Dissection (ALND)
NA · 1 location(s) · University of Cincinnati · NCT07528638Targeted Resection of Axillary Metastatic Lymph Nodes After Breast Cancer Neoadjuvant Chemotherapy
NA · 1 location(s) · Second Affiliated Hospital, School of Medicine, Zhejiang Uni · NCT04744506A Study of a Comprehensive Prevention Program to Reduce Lymphedema After Axillary Lymph Node Dissection in People With B
Phase 3 · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT06144164Lymphedema Surveillance Study
Phase N/A · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT02743858ALND vs ART in Positive Sentinel Node After Neoadjuvant Therapy in Breast Cancer
NA · 60 location(s) · Hospital Universitari de Bellvitge · NCT04889924
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.